López-Trascasa M - Search Results

1

Interaction of C3 nephritic factor (NEF) with erythrocyte membranes complement-independent binding to sheep and patients' erythrocytes.

Marin MA, Fontán G, López-Trascasa M. Marin MA, et al. Mol Immunol. 1991 Jan-Feb;28(1-2):133-40. doi: 10.1016/0161-5890(91)90096-3. Mol Immunol. 1991. PMID: 2011122

2

Molecular characterization of Complement Factor I deficiency in two Spanish families.

Ponce-Castro IM, González-Rubio C, Delgado-Cerviño EM, Abarrategui-Garrido C, Fontán G, Sánchez-Corral P, López-Trascasa M. Ponce-Castro IM, et al. Mol Immunol. 2008 May;45(10):2764-71. doi: 10.1016/j.molimm.2008.02.008. Epub 2008 Mar 28. Mol Immunol. 2008. PMID: 18374984

3

Requirements for the production of high-titre C3 nephritic factor (NEF) antibody in vitro.

Marín MA, Fontán G, López-Trascasa M. Marín MA, et al. Immunology. 1992 Jun;76(2):318-23. Immunology. 1992. PMID: 1321794 Free PMC article.

4

Familial incidence of C3 nephritic factor.

López-Trascasa M, Martín-Villa JM, Vicario JL, Marín MA, Martínez-Ara J, García-Messeguer MC, Arnáiz-Villena A, Fontán G. López-Trascasa M, et al. Nephron. 1991;59(2):261-5. doi: 10.1159/000186562. Nephron. 1991. PMID: 1956487

5

Determination of C3 nephritic factor activity by a microassay based on the peroxidase-like activity of the heme group.

Marín MA, Domingo A, Fontán G, López-Trascasa M. Marín MA, et al. Clin Biochem. 1990 Dec;23(6):497-9. doi: 10.1016/0009-9120(90)80038-k. Clin Biochem. 1990. PMID: 1963123

6

Interaction between C3 nephritic factor and erythrocyte membranes. Presence of nephritic factor in patients' erythrocytes.

López-Trascasa M, Marín MA, Fontán G. López-Trascasa M, et al. Complement. 1988;5(4):165-73. doi: 10.1159/000463053. Complement. 1988. PMID: 3203499

7

Factor J, a human inhibitor of complement C1, is a cationic, highly glycosylated protein.

Jiménez-Clavero MA, González-Rubio C, Fontán G, López-Trascasa M. Jiménez-Clavero MA, et al. Immunol Lett. 1994 Oct;42(3):185-90. doi: 10.1016/0165-2478(94)90084-1. Immunol Lett. 1994. PMID: 7890318

8

The inhibitory effect of factor J on the alternative complement pathway.

González-Rubio C, Jiménez-Clavero MA, Fontán G, López-Trascasa M. González-Rubio C, et al. J Biol Chem. 1994 Oct 21;269(42):26017-24. J Biol Chem. 1994. PMID: 7929312 Free article.

9

Polyclonal autoantibodies against C1 inhibitor in a case of acquired angioedema.

Ponce IM, Caballero T, Reche M, Piteiro AB, López-Serrano MC, Fontán G, López-Trascasa M. Ponce IM, et al. Ann Allergy Asthma Immunol. 2002 Jun;88(6):632-7. doi: 10.1016/S1081-1206(10)61896-0. Ann Allergy Asthma Immunol. 2002. PMID: 12086372

10

C5 complement deficiency in a Spanish family. Molecular characterization of the double mutation responsible for the defect.

Delgado-Cerviño E, Fontán G, López-Trascasa M. Delgado-Cerviño E, et al. Mol Immunol. 2005 Jan;42(1):105-11. doi: 10.1016/j.molimm.2004.06.036. Mol Immunol. 2005. PMID: 15488949

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters